Chronic Spontaneous Urticaria
Chronic spontaneous urticaria (CSU) is a condition where hives or welts appear on the skin for six weeks or longer without a known cause. It can cause significant discomfort and itching.
We are comparing a new treatment, BP11, to Xolair for patients with chronic spontaneous urticaria who haven't responded to antihistamines. The goal is to see if BP11 is as effective and safe as Xolair.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic spontaneous urticaria (CSU) is a condition where hives or welts appear on the skin for six weeks or longer without a known cause. It can cause significant discomfort and itching.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.